FORT WORTH, Texas / May 22, 2025 / Business Wire / Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced updates to its second quarter and full year 2025 outlook for Non-GAAP EBITDA and Non-GAAP earnings per share, and the authorization of a new $75 million stock repurchase program. “The... Read More

RFID-Enabled Dispensing and Intelligent Inventory Management Software Aim to Unlock Greater Inventory Accuracy and Streamline Medication Management in Operating Rooms and Outpatient Clinics FORT WORTH, Texas / May 14, 2025 / Business Wire / Omnicell, Inc . (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced new products designed to streamline... Read More

Company Establishes New Hub Dedicated to Addressing Challenges Across the Medication Journey AUSTIN, Texas / May 14, 2025 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced the opening of its Innovation Lab, located at 1005 East St. Elmo Road in Austin, Texas. The facility will serve as a hub focused on... Read More

Omnicell delivers solid first quarter financial results Results exceed previously issued first quarter 2025 guidance for total revenues and non-GAAP EPS Updates full year 2025 non-GAAP EBITDA and non-GAAP EPS guidance FORT WORTH, Texas / May 06, 2025 / Business Wire / Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy and nursing care delivery... Read More

FORT WORTH, Texas / Apr 14, 2025 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the first quarter 2025, before market open on Tuesday, May 6, 2025. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day. All interested parties are invited to listen to the... Read More

Medical device, pharmaceutical, and life sciences expert tapped to lead Company’s technology strategy and global engineering organization FORT WORTH, Texas / Mar 24, 2025 / Business Wire / Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced that Perry A. Genova, PhD, will join the Company as Senior Vice President, Chief Technology... Read More

Company Reiterates First Quarter and Full Year 2025 Guidance FORT WORTH, Texas / Mar 12, 2025 / Business Wire / Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced that Nchacha Etta will be stepping down from his role as Executive Vice President and Chief Financial Officer, effective September 15,... Read More

Omnicell delivers strong fourth quarter financial results Results exceed previously issued full year guidance for bookings, total revenues, and non-GAAP EBITDA FORT WORTH, Texas / Feb 06, 2025 / Business Wire / Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced results for its fiscal year and... Read More

FORT WORTH, Texas / Jan 13, 2025 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the fourth quarter and full year 2024, before market open on Thursday, February 6, 2025. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day. All interested parties are... Read More

FORT WORTH, Texas / Jan 09, 2025 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 at 1:30 p.m. PT. Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/ About... Read More

Next-generation, cloud native, software workflow engine and data platform intended to seamlessly integrate enterprise robotics and smart devices across the continuum of care Company Showcases New and Enhanced Outcomes-Centric Innovation at ASHP Midyear 2024 FORT WORTH, Texas / Dec 09, 2024 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care... Read More

FORT WORTH, Texas / Nov 22, 2024 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024 at 2:00 p.m. ET. Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/ About... Read More

FORT WORTH, Texas / Nov 20, 2024 / Business Wire / Omnicell, Inc. (NASDAQ: OMCL) (“Omnicell”) today announced the pricing of $150.0 million aggregate principal amount of 1.00% Convertible Senior Notes due 2029 (the “notes”) in a private placement (the “offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).... Read More

FORT WORTH, Texas / Nov 18, 2024 / Business Wire / Omnicell, Inc. (NASDAQ: OMCL) (“Omnicell”) today announced that it intends to offer, subject to market conditions and other factors, $150.0 million aggregate principal amount of Convertible Senior Notes due 2029 (the “notes”) in a private placement (the “offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities... Read More

Omnicell delivers solid third quarter financial results Total revenues of $282 million GAAP net income per diluted share of $0.19 Non-GAAP net income per diluted share of $0.56 Raises 2024 non-GAAP EBITDA and non-GAAP earnings per share guidance FORT WORTH, Texas / Oct 30, 2024 / Business Wire / Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy... Read More

FORT WORTH, Texas / Oct 07, 2024 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will release its financial results for the third quarter 2024, before market open on Wednesday, October 30, 2024. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day. All interested parties are invited to listen to the live... Read More

The Company taps business and operations executive with expertise that spans healthcare and med tech to help scale pharmacy automation and drive multi-year innovation and excellence FORT WORTH, Texas / Sep 25, 2024 / Business Wire / Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the... Read More

Full-Service, Scalable Solution Designed to Help Health Systems Establish and Continuously Optimize Centralized Medication Management Operations FORT WORTH, Texas / Aug 20, 2024 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, today announced Central Med Automation... Read More

FORT WORTH, Texas / Aug 15, 2024 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the 2024 Wells Fargo Healthcare Conference on Thursday, September 5, 2024 at 1:30 p.m. ET. Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/ About Omnicell... Read More

Good Neighbor Pharmacy Launches EnlivenHealth’s New Scope of Practice and Reimbursement Snapshot at ThoughtSpot Designed to Drive Clinical Service Expansion, Reimbursement and Patient Care in Community Pharmacy FORT WORTH, Texas / Aug 01, 2024 / Business Wire / EnlivenHealth, a division of Omnicell, Inc. , is pleased to announce the release of a first-of-a-kind Scope of Practice and Reimbursement Snapshot solution for... Read More

Results exceed previously issued second quarter guidance across all metrics Total revenues of $277 million GAAP net income per diluted share of $0.08 Non-GAAP net income per diluted share of $0.51 Raises 2024 non-GAAP EBITDA and non-GAAP earnings per share guidance FORT WORTH, Texas / Aug 01, 2024 / Business Wire / Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in... Read More

FORT WORTH, Texas / Jul 15, 2024 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will release its financial results for the second quarter 2024, before market open on Thursday, August 1, 2024. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day. All interested parties are invited to listen to the live... Read More

FORT WORTH, Texas / May 06, 2024 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced continued support for the global charity Mercy Ships with the donation of solutions from the recently announced XT Amplify program. The... Read More

FORT WORTH, Texas / May 03, 2024 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the BofA Securities 2024 Health Care Conference in Las Vegs, NV, on Wednesday, May 15, 2024 at 3:40 p.m. PT. Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/ About Omnicell... Read More

Results exceed prior first quarter guidance across all metrics Total GAAP revenues of $246 million FORT WORTH, Texas / May 02, 2024 / Business Wire / Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced results for its first quarter ended March 31, 2024. Randall Lipps, chairman, president, chief executive... Read More

Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System FORT WORTH, Texas / Apr 16, 2024 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced XT Amplify, a multi-year innovation... Read More

FORT WORTH, Texas / Apr 08, 2024 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will release its financial results for the first quarter 2024, before market open on Thursday, May 2, 2024. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day. All interested parties are invited to listen to the live call... Read More

FORT WORTH, Texas / Mar 11, 2024 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum on Wednesday, March 20, 2024 at 4:30 p.m. ET. Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/ About... Read More

Full Year 2023 GAAP Revenues of $1.147 billion Full Year 2023 GAAP net loss of $20 million and GAAP net loss per diluted share of $0.45 Full Year 2023 Non-GAAP EBITDA of $138 million and Non-GAAP net income per diluted share of $1.91 Full Year 2023 Net Cash Provided by Operating Activities of $181 million Full Year 2023 Non-GAAP Free Cash Flow of $126 million FORT WORTH, Texas / Feb 08, 2024 / Business Wire / Omnicell, Inc.... Read More

FORT WORTH, Texas / Jan 16, 2024 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full year 2023, before market open on Thursday, February 8, 2024. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that... Read More

Sales and Operational Veteran Brings Additional Global Business Experience and Healthcare Technology Expertise to Board FORT WORTH, Texas / Jan 11, 2024 / Business Wire / Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced that the Board of... Read More

FORT WORTH, Texas / Nov 27, 2023 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will present at the Piper Sandler 35 th Annual Healthcare Conference on Tuesday, November 28, 2023 at 1:00 p.m. ET. Live and archived webcasts of the presentation will be available through the Omnicell website at:... Read More

Advanced Services for Central Pharmacy Dispensing Designed to Support Dispensing Accuracy and Patient Safety while Improving Clinical and Financial Outcomes FORT WORTH, Texas / Nov 02, 2023 / Business Wire / Omnicell, Inc. (Nasdaq: OMCL), a leader in transforming the pharmacy care delivery model, today announced that Kentucky-based Baptist Health has selected Omnicell’s Central Pharmacy Dispensing Service in an effort to... Read More

Total GAAP revenues of $299 million GAAP net income per diluted share of $0.12 Non-GAAP net income per diluted share of $0.62 FORT WORTH, Texas / Nov 02, 2023 / Business Wire / Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced results for its third quarter ended September 30, 2023. Randall Lipps, chairman,... Read More

FORT WORTH, Texas / Aug 23, 2023 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the 2023 Wells Fargo Healthcare Conference on Wednesday, September 6, 2023 at 3:00 p.m. ET. Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/ About Omnicell... Read More

Total GAAP revenues of $299 million GAAP net income per diluted share of $0.08 Non-GAAP net income per diluted share of $0.57 FORT WORTH, Texas / Aug 01, 2023 / Business Wire / Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced results for its second quarter ended June 30, 2023. “Our second quarter results... Read More

FORT WORTH, Texas / Jul 12, 2023 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the second quarter 2023, after market close on Tuesday, August 1, 2023. The Company will host a conference call and webcast to discuss its financial results at 4:30 p.m. ET that same day. All... Read More

Established Leader Brings Global SaaS and Healthcare Technology Experience to Board FORT WORTH, Texas / Jul 11, 2023 / Business Wire / Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced it has increased its number of board seats from 9 to 10, and has appointed Kaushik “Bobby” Ghoshal to fill the newest seat as an independent director of... Read More

Sanchez, Who Joined EmpiRx Health Earlier this Year as President, Assumes CEO Role – Reinforces Commitment to Company's Healthcare Mission MONTVALE, N.J. , June 1, 2023 /PRNewswire/ -- EmpiRx Health , the industry's only value-based PBM, today announced that the company's president, Danny Sanchez , has been named Chief Executive Officer. As part of a planned transition, Sanchez succeeds Karthik Ganesh who has served as... Read More

FORT WORTH, Texas / May 30, 2023 / Business Wire / Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced changes to its leadership structure designed to create a more streamlined organization with a continued focus on operational excellence, driving continuous improvements in customer experience and the delivery of Omnicell’s long-term... Read More

Seasoned Leader Brings Over Two Decades of Finance and Accounting Experience to Omnicell FORT WORTH, Texas / May 15, 2023 / Business Wire / Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced that Nchacha E. Etta has been appointed Executive Vice President and Chief Financial Officer of the Company, effective June 1, 2023. Mr. Etta succeeds... Read More

FORT WORTH, Texas / May 03, 2023 / Business Wire / Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, announced that it will present at the BofA Securities 2023 Healthcare Conference on Thursday, May 11, 2023 at 8:00 a.m. PT. Live and archived webcasts of the presentation will be available through the Omnicell website at:... Read More

Total GAAP revenues of $291 million GAAP net loss per diluted share of $0.33 Non-GAAP net income per diluted share of $0.39 FORT WORTH, Texas / May 02, 2023 / Business Wire / Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced results for its first quarter ended March 31, 2023. “We are pleased with the... Read More

Strategic Initiative Expected to Enhance Technological Capabilities, Advance the Practice of Pharmacy & Enable Support of Safe Medication Management BROOKLYN, N.Y. / Apr 20, 2023 / Business Wire / Long Island University and Omnicell, Inc. (Nasdaq: OMCL) (Omnicell), a leading provider of medication management and adherence... Read More

FORT WORTH, Texas / Apr 12, 2023 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the first quarter 2023 after market close on Tuesday, May 2, 2023. The Company will host a conference call and webcast to discuss its financial results at 4:30 p.m. ET that same day. All... Read More

The first sentence of the second paragraph of the release dated Feb. 15, 2023, has been corrected to replace the dial-in numbers for the earnings call on Tuesday, February 28, 2023. The updated release reads: SANTA CLARA, Calif. / Feb 16, 2023 / Business Wire / OMNICELL TO RELEASE FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS ON FEBRUARY 28, 2023 Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management... Read More

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full year 2022, after market on Tuesday, February 28, 2023. The Company will host a conference call and webcast to discuss its financial results at 4:30 p.m. ET that same day. All interested parties are invited to listen to... Read More

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced that they will present at the 41 st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 8:15 a.m. Pacific Time. Live and archived webcasts of the presentation will be available through the Omnicell website at:... Read More